Global Influenza Vaccine Market - Strategic Insights and Forecasts (2026-2031)

The Global Influenza Vaccine Market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.3% between 2026 and 2031. This growth trajectory is expected to increase the market size from USD 8.3 billion in 2026 to USD 11.7 billion by 2031.

Three verified forces drive demand: annual WHO strain recommendations creating recurring procurement cycles, public immunization programs funding large centralized purchases for high-risk groups, and technology diversification. Notably, mRNA and combination influenza/COVID candidates achieving positive Phase 3 readouts or regulatory interactions are raising demand for new fill/finish capacity and adjuvants.

The shift towards new vaccine formats and platforms, such as mRNA combination candidates and policy changes regarding trivalent vs. quadrivalent vaccines, is significantly impacting the market. These changes have increased demand for clinical manufacturing capacity and adjuvants, while also compressing time-to-market for crucial strain updates.

Public-sector procurement and national immunization campaigns, exemplified by initiatives from the US CDC, Brazil PNI, and South Africa NDOH, remain the dominant demand pull. Conversely, private market uptake for influenza vaccines is primarily concentrated in high-income countries.

Corporate activity in 2024–2025 significantly affected production and commercial planning, with Moderna and Sanofi advancing clinical data and regulatory interactions for combination/fast-track designations. Additionally, legacy manufacturers like GSK and Seqirus conducted broad seasonal shipments, materially impacting market dynamics.

The U.S. tariff environment exerts a favorable influence on the global influenza vaccine market because human vaccines imported under HTS classifications such as 3002.20 or 3002.41 are subject to a zero-duty regime. This duty-free status reduces import-related cost burdens for overseas manufacturers, supporting cross-border supply and enhancing the strategic attractiveness of the United States as a high-value destination.